1. Curcumin and its derivatives in breast cancer: Current developments and potential for the treatment of drug-resistant cancers
   Belinda J Cridge et al, 2013, Oncology Discovery CrossRef
2. Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy
   Rama I. Mahran et al, 2017, The AAPS Journal CrossRef
3. Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma
   Stefanie Kewitz et al, 2013, Cancer Growth and Metastasis CrossRef
4. Curcumin inhibits the replication of enterovirus 71 in vitro
   Ying Qin et al, 2014, Acta Pharmaceutica Sinica B CrossRef
5. Curcumin inhibits growth potential by G1 cell cycle arrest and induces apoptosis in p53-mutated COLO 320DM human colon adenocarcinoma cells
   Jade Dhananjay Dasiram et al, 2017, Biomedicine & Pharmacotherapy CrossRef
6. Curcumin and its Derivatives Targeting Multiple Signaling Pathways to Elicit Anticancer Activity: A Comprehensive Perspective
   Firdous Fatima et al, 2024, Current Medicinal Chemistry CrossRef
7. Curcumin-derivative nanomicelles for the treatment of triple negative breast cancer
   Sebastien Taurin et al, 2013, Journal of Drug Targeting CrossRef
8. Protective effect of curcumin against heavy metals-induced liver damage
   Wylly Ramsés García-Niño et al, 2014, Food and Chemical Toxicology CrossRef
9. Cadmium‐induced toxicity is rescued by curcumin: A review
   Mohammad Mohajeri et al, 2017, BioFactors CrossRef
10. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER-negative breast cancer models
    BABASAHEB YADAV et al, 2012, International Journal of Oncology CrossRef
11. Utility of the second-generation curcumin analogue RL71 in canine histiocytic sarcoma
    Barnaby Kelly et al, 2024, Veterinary Research Communications CrossRef
12. Pculin02H, a curcumin derivative, inhibits proliferation and clinical drug resistance of HER2-overexpressing cancer cells
    Jin-Cherng Lien et al, 2015, Chemico-Biological Interactions CrossRef
13. Small-molecule RL71-triggered excessive autophagic cell death as a potential therapeutic strategy in triple-negative breast cancer
    Jian Gao et al, 2017, Cell Death & Disease CrossRef
14. Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer
    Shuli Chen et al, 2017, International Journal of Oncology CrossRef
15. Modified Curcumins as Potential Drug Candidates for Breast Cancer: An Overview
    Abigail L. Flint et al, 2022, Molecules CrossRef
16. The second‐generation curcumin analogue RL71 elicits G2/M cell cycle arrest and apoptosis in canine osteosarcoma cells
    Barnaby Kelly et al, 2023, Veterinary and Comparative Oncology CrossRef
17. ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models
    Snehal Nirgude et al, 2020, Molecules CrossRef
18. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer
    Bryant W. Megna et al, 2017, Journal of Surgical Research CrossRef
19. Mechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin – An in vitro and in silico approach
    Kumaravel Mohankumar et al, 2014, Chemico-Biological Interactions CrossRef
20. A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines
    SEBASTIEN TAURIN et al, 2016, International Journal of Oncology CrossRef
21. Small molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancer
    Baofang Yang et al, 2015, Oncotarget CrossRef